Warburg Commits to Invest CDN$35 Million in Protox

Warburg Pincus has committed to invest CDN$35 million in Protox, which develops receptor targeted fusion proteins for the treatment of diseases of the prostate and cancer. Warburg is a global PE firm.

DealsNorth AmericaUSBriefs